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Background
For clinicians involved in managing the foot with rheu-
matoid arthritis (RA), there is a dearth of patient-
reported outcome measures (PROs) available with only
the Leeds Foot Impact Scale (LFIS). The LFIS currently
lacks evidence for important measurement properties,
does not permit a patient-specific assessment strategy
and was designed using a restrictive scaling strategy.
Therefore, the aim of this research was to develop a new
PRO, the Salford Rheumatoid Arthritis Foot Evaluation
Instrument (SAFE), working closely with clinicians and
patients, to create an instrument with multiple assess-
ment strategies (fixed and patient-specific) and rigorous
measurement properties.
Methods
Development of the SAFE was divided into 4 stages:
conceptual basis and content development, clinimetric
instrument development, instrument pre-testing and
demonstration of instrument measurement properties,
including construct validity and temporal stability of the
fixed scale.
Results
A total of 123 items were initially generated for the
SAFE, with 25 of them clinimetrically selected for the
fixed scale and 80 items initially included in the patient-
specific scale. The pretesting strategy proved effective for
improving and refining the SAFE, with the final draft
consisting of 19 items in the fixed and 42 items in the
patient-specific scale. The fixed scale has strong evidence
for validity and temporal stability.
Conclusion
With further development to demonstrate additional
measurement properties, the SAFE may prove a valuable
tool for clinicians involved in managing the foot with
RA, enhancing patient centred care and facilitating com-
munication between clinicians and patients. The SAFE
may also have application as an outcome measure for
research and evidence-based practice.
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